363 related articles for article (PubMed ID: 38187049)
1. The role of nanoparticles and nanomaterials in cancer diagnosis and treatment: a comprehensive review.
Lan H; Jamil M; Ke G; Dong N
Am J Cancer Res; 2023; 13(12):5751-5784. PubMed ID: 38187049
[TBL] [Abstract][Full Text] [Related]
2. Revolutionizing Cancer Care: Advances in Carbon-Based Materials for Diagnosis and Treatment.
Khan MZ; Tahir D; Asim M; Israr M; Haider A; Xu DD
Cureus; 2024 Jan; 16(1):e52511. PubMed ID: 38371088
[TBL] [Abstract][Full Text] [Related]
3. Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.
Kashyap BK; Singh VV; Solanki MK; Kumar A; Ruokolainen J; Kesari KK
ACS Omega; 2023 Apr; 8(16):14290-14320. PubMed ID: 37125102
[TBL] [Abstract][Full Text] [Related]
4. Current Progress in Cancer Treatment Using Nanomaterials.
Zhu R; Zhang F; Peng Y; Xie T; Wang Y; Lan Y
Front Oncol; 2022; 12():930125. PubMed ID: 35912195
[TBL] [Abstract][Full Text] [Related]
5. Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect.
Karati D; Mukherjee S; Dutta A; Ash D; Ganguly SC; Acharya A; Basu B
Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38756071
[TBL] [Abstract][Full Text] [Related]
6. Polymeric multifunctional nanomaterials for theranostics.
Peng H; Liu X; Wang G; Li M; Bratlie KM; Cochran E; Wang Q
J Mater Chem B; 2015 Sep; 3(34):6856-6870. PubMed ID: 32262535
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics.
Tiwari H; Rai N; Singh S; Gupta P; Verma A; Singh AK; Kajal ; Salvi P; Singh SK; Gautam V
Bioengineering (Basel); 2023 Jun; 10(7):. PubMed ID: 37508788
[TBL] [Abstract][Full Text] [Related]
10. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
11. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
12. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
Fernandez-Fernandez A; Manchanda R; McGoron AJ
Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
[TBL] [Abstract][Full Text] [Related]
13. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
Liang H; Zhang XB; Lv Y; Gong L; Wang R; Zhu X; Yang R; Tan W
Acc Chem Res; 2014 Jun; 47(6):1891-901. PubMed ID: 24780000
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
15. Advances in intelligent-responsive nanocarriers for cancer therapy.
Tian M; Xin X; Wu R; Guan W; Zhou W
Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterials for cancer therapy: current progress and perspectives.
Cheng Z; Li M; Dey R; Chen Y
J Hematol Oncol; 2021 May; 14(1):85. PubMed ID: 34059100
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for Cancer Therapy: Current Progress and Challenges.
Gavas S; Quazi S; Karpiński TM
Nanoscale Res Lett; 2021 Dec; 16(1):173. PubMed ID: 34866166
[TBL] [Abstract][Full Text] [Related]
18. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hsu HJ; Bugno J; Lee SR; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
[TBL] [Abstract][Full Text] [Related]
20. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
